(Q59649682)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Andrea Gallina

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1

Pierre I Karakiewicz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

5

Paul Perrotte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

3

Quoc-Dien Trinh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

7

Jacques Tostain

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Georg C Hutterer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jean-Jacques Patard

series ordinal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

1241-1247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Serum C-reactive protein level and the impact of cytoreductive surgery in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Metastatic renal carcinoma comprehensive prognostic system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Significant prognostic factors for 5-year survival after curative resection of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Improved prognostication of renal cell carcinoma using an integrated staging system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

The acute phase response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Judging New Markers by Their Ability to Improve Predictive Accuracy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Tumor size improves the accuracy of TNM predictions in patients with renal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Immunotherapy for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Dichotomizing continuous predictors in multiple regression: a bad idea

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Factors influencing between-laboratory variability of C-reactive protein results as evidenced by the Belgian External Quality Assessment(EQA) Scheme

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22896

7 January 2021

Identifiers

DOI

10.1002/CNCR.22896

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17639589%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference